Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1979 Jun;24(3):628–636. doi: 10.1128/iai.24.3.628-636.1979

Leukocyte cytotoxicity in a persistent virus infection: presence of direct cytotoxicity but absence of antibody-dependent cellular cytotoxicity in horses infected with equine infectious anemia virus.

Y Fujimiya, L E Perryman, T B Crawford
PMCID: PMC414352  PMID: 223981

Abstract

Antibody-dependent cellular cytotoxicity and direct cytotoxicity assays were performed with equine infectious anemia virus-infected target cells, equine leukocytes, and equine anti-equine infectious anemia virus antibody to determine whether these mechanisms play a role in controlling viral replication in equine infectious anemia. Direct cytotoxicity was observed by using peripheral blood mononuclear cells from 7 of 10 infected horses. Antibody-dependent cellular cytotoxicity was not observed. The antibody-dependent cellular cytotoxicity reaction in horses was then studied by using sheep erythrocytes and trinitrophenylated sheep erythrocytes as target cells. Lysis of these target cells was mediated by neutrophils, monocytes, and lymphocytes. The reaction was activated by antibody of the immunoglobulin G class but not by immunoglobulin G(T). Furthermore, immunoglobulin G(T) efficiently inhibited immunoglobulin G in this function.

Full text

PDF
628

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson T., Stejskal V., Harfast B. An in vitro method for study of human lymphocyte cytotoxicity against mumps-virus-infected target cells. J Immunol. 1975 Jan;114(1 Pt 1):237–243. [PubMed] [Google Scholar]
  2. Archer B. G., Crawford T. B., McGuire T. C., Frazier M. E. RNA-dependent DNA polymerase associated with equine infectious anemia virus. J Virol. 1977 Apr;22(1):16–22. doi: 10.1128/jvi.22.1.16-22.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Banks K. L., Henson J. B., McGuire T. C. Immunologically mediated glomerulitis of horses. I. Pathogenesis in persistent infection by equine infectious anemia virus. Lab Invest. 1972 Jun;26(6):701–707. [PubMed] [Google Scholar]
  4. Banks K. L., McGuire T. C. Surface receptors on neutrophils and monocytes from immunodeficient and normal horses. Immunology. 1975 Mar;28(3):581–588. [PMC free article] [PubMed] [Google Scholar]
  5. Banks K. L. Monocyte activation in horses persistently infected with equine infectious anemia virus. Infect Immun. 1975 Nov;12(5):1219–1221. doi: 10.1128/iai.12.5.1219-1221.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Berger A. E., Amos D. B. A comparison of antibody-dependent cellular cytotoxicity (ADCC) mediated by murine and human lymphoid cell populations. Cell Immunol. 1977 Oct;33(2):277–290. doi: 10.1016/0008-8749(77)90158-7. [DOI] [PubMed] [Google Scholar]
  7. Blair P. B., Lane M. A., Mar P. Antibody in the sera of tumor-bearing mice that mediates spleen cell cytotoxicity toward the autologous tumor. J Immunol. 1976 Mar;116(3):606–609. [PubMed] [Google Scholar]
  8. Charman H. P., Bladen S., Gilden R. V., Coggins L. Equine infectious anemia virus: evidence favoring classification as a retravirus. J Virol. 1976 Sep;19(3):1073–1079. doi: 10.1128/jvi.19.3.1073-1079.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cheevers W. P., Archer B. G., Crawford T. B. Characterization of RNA from equine infectious anemia virus. J Virol. 1977 Nov;24(2):489–497. doi: 10.1128/jvi.24.2.489-497.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chiba Y., Dzierba J. L., Morag A., Ogra P. L. Cell-mediated immune response to mumps virus infection in man. J Immunol. 1976 Jan;116(1):12–15. [PubMed] [Google Scholar]
  11. Coggins L., Norcross N. L. Immunodiffusion reaction in equine infectious anemia. Cornell Vet. 1970 Apr;60(2):330–335. [PubMed] [Google Scholar]
  12. Gale R. P., Zighelboim J. Polymorphonuclear leukocytes in antibody-dependent cellular cytotoxicity. J Immunol. 1975 Mar;114(3):1047–1051. [PubMed] [Google Scholar]
  13. Greenberg A. H., Shen L., Medley G. Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. I. Phagocytic and non-phagocytic effector cell activity against erythrocyte and tumour target cells in a 51Cr release cytotoxicity assay and [125I]IUdR growth inhibition assay. Immunology. 1975 Oct;29(4):719–729. [PMC free article] [PubMed] [Google Scholar]
  14. Grewal A. S., Rouse B. T., Babiuk L. A. Mechanisms of resistant of herpesviruses: comparison of the effectiveness of different cell types in mediating antibody-dependent cell-mediated cytotoxicity. Infect Immun. 1977 Mar;15(3):698–703. doi: 10.1128/iai.15.3.698-703.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Henson J. B., McGuire T. C. Equine infectious anemia. Prog Med Virol. 1974;18(0):143–159. [PubMed] [Google Scholar]
  16. Hodgin E. C., McGuire T. C., Perryman L. E., Grant B. D. Evaluation of delayed hypersensitivity responses in normal horses and immunodeficient foals. Am J Vet Res. 1978 Jul;39(7):1161–1167. [PubMed] [Google Scholar]
  17. Härfast B., Andersson T., Grandien M. Enhanced cytotoxicity of human lymphocytes against rabies-infected cells by rabies-specific antibodies. Scand J Immunol. 1977;6(11):1107–1112. doi: 10.1111/j.1365-3083.1977.tb00348.x. [DOI] [PubMed] [Google Scholar]
  18. Härfast B., Andersson T., Perlmann P. Human lymphocyte cytotoxicity against mumps virus-infected target cells. Requirement for non-T cells. J Immunol. 1975 Jun;114(6):1820–1823. [PubMed] [Google Scholar]
  19. Ishii S., Ishitani R. Equine infectious anemia. Adv Vet Sci Comp Med. 1975;19:195–222. [PubMed] [Google Scholar]
  20. Jondal M. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis. Clin Exp Immunol. 1976 Jul;25(1):1–5. [PMC free article] [PubMed] [Google Scholar]
  21. Joseph B. S., Perrin L. H., Oldstone M. B. Measurement of virus antigens on the surface of HeLa cells persistently infected with wild type and vaccine strains of measles virus by radioimmune assay. J Gen Virol. 1976 Mar;30(3):329–337. doi: 10.1099/0022-1317-30-3-329. [DOI] [PubMed] [Google Scholar]
  22. Kono Y., Kobayashi K., Fukunaga Y. Antigenic drift of equine infectious anemia virus in chronically infected horses. Arch Gesamte Virusforsch. 1973;41(1):1–10. doi: 10.1007/BF01249923. [DOI] [PubMed] [Google Scholar]
  23. Kono Y., Kobayashi K., Fukunaga Y. Serological comparison among various strains of equine infectious anemia virus. Arch Gesamte Virusforsch. 1971;34(3):202–208. doi: 10.1007/BF01242993. [DOI] [PubMed] [Google Scholar]
  24. Kovithavongs T., Rice G., Thong K. L., Dossetor J. B. Effector cell activity in antibody mediated cell dependent immune lysis. II. Evidence for different populations of effector cells for different targets. Cell Immunol. 1975 Jul;18(1):167–175. doi: 10.1016/0008-8749(75)90045-3. [DOI] [PubMed] [Google Scholar]
  25. Labowskie R., Edelman R., Rustigian R., Bellanti J. A. Studies of cell-mediated immunity to measles virus by in vitro lymphocyte-mediated cytotoxicity. J Infect Dis. 1974 Mar;129(3):233–239. doi: 10.1093/infdis/129.3.233. [DOI] [PubMed] [Google Scholar]
  26. Lamon E. W., Shaw M. W., Goodson S., Lidin B., Walia A. S., Fuson E. W. Antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: differential activity of IgG and IgM with different subpopulations of lymphocytes. J Exp Med. 1977 Feb 1;145(2):302–313. doi: 10.1084/jem.145.2.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lamon E. W., Skurzak H. M., Andersson B., Whitten H. D., Klein E. Antibody-dependent lymphocyte cytotoxicity in the murine sarcoma virus system: activity of IgM and IgG with specificity for MLV determined antigen(s). J Immunol. 1975 Apr;114(4):1171–1176. [PubMed] [Google Scholar]
  28. Ley K. D., Burger D., McGuire T., Henson J. B. Equine interferon: absence in equine infectious anemia and kinetics of induction in equine cells. J Infect Dis. 1970 Jul-Aug;122(1):10–15. doi: 10.1093/infdis/122.1-2.10. [DOI] [PubMed] [Google Scholar]
  29. MacDonald H. R., Bonnard G. D., Sordat B., Zawodnik S. A. Antibody-dependent cell-mediated cytotoxicity: heterogeneity of effector cells in human peripheral blood. Scand J Immunol. 1975 Sep;4(5-6):487–497. doi: 10.1111/j.1365-3083.1975.tb02654.x. [DOI] [PubMed] [Google Scholar]
  30. MacLennan I. C. Antibody in the induction and inhibition of lymphocyte cytotoxicity. Transplant Rev. 1972;13:67–90. doi: 10.1111/j.1600-065x.1972.tb00060.x. [DOI] [PubMed] [Google Scholar]
  31. Malmquist W. A., Barnett D., Becvar C. S. Production of equine infectious anemia antigen in a persistently infected cell line. Arch Gesamte Virusforsch. 1973;42(4):361–370. doi: 10.1007/BF01250717. [DOI] [PubMed] [Google Scholar]
  32. McGuire T. C., Crawford T. B., Henson J. B. Equine infectious anemia: detection of infections virus-antibody complexes in the serum. Immunol Commun. 1972;1(6):545–551. doi: 10.3109/08820137209022963. [DOI] [PubMed] [Google Scholar]
  33. McGuire T. C., Crawford T. B. Induction of a cell membrane antigen by equine infectious anemia virus. Am J Vet Res. 1978 Mar;39(3):385–386. [PubMed] [Google Scholar]
  34. McGuire T. C., Henson J. B., Burger D. Complement (C'3)-coated red blood cells following infection with the virus of equine infectious anemia. J Immunol. 1969 Aug;103(2):293–299. [PubMed] [Google Scholar]
  35. McGuire T. C. Immunoglobulin G subclass [IgG and IgG(T)] interaction with the P26 group specific antigen of equine infectious anemia virus: immunodiffusion and complement-fixation reactions. Am J Vet Res. 1977 May;38(5):655–658. [PubMed] [Google Scholar]
  36. McGuire T. C. Suppression of synthesis of an IgG subclass in a persistent viral infection. Immunology. 1976 Jan;30(1):17–24. [PMC free article] [PubMed] [Google Scholar]
  37. McGuire T. C., Van Hoosier G. L., Jr, Henson J. B. The complement-fixation reaction in eguine infectious anemia: demonstration of inhibition by IgG (T). J Immunol. 1971 Dec;107(6):1738–1744. [PubMed] [Google Scholar]
  38. NAKAMURA H., KATSURA T. IMMUNOCHEMICAL STUDIES ON DIPHTHERIA ANTITOXIN. VI. COMPARATIVE STUDIES OF HORSE T AND GAMMA ANTITOXINS IN THE QUANTITATIVE PRECIPITIN REACTION, COMPLEMENT FIXATION, AND INDIRECT HEMAGGLUTINATION OF TANNED AND TOXIN-COATED ERYTHROCYTES. Jpn J Exp Med. 1964 Aug;34:167–196. [PubMed] [Google Scholar]
  39. Nakajima H., Tanaka S., Ushimi C. Physicochemical studies of equine infectious anemia virus. I. Buoyant density of the virus. Arch Gesamte Virusforsch. 1969;26(4):389–394. doi: 10.1007/BF01250949. [DOI] [PubMed] [Google Scholar]
  40. Perlmann P., Perlmann H. Contactual lysis of antibody-coated chicken erythrocytes by purified lymphocytes. Cell Immunol. 1970 Sep;1(3):300–315. doi: 10.1016/0008-8749(70)90051-1. [DOI] [PubMed] [Google Scholar]
  41. Perlmann P., Perlmann H., Wigzell H. Lymphocyte mediated cytotoxicity in vitro. Induction and inhibition by humoral antibody and nature of effector cells. Transplant Rev. 1972;13:91–114. doi: 10.1111/j.1600-065x.1972.tb00061.x. [DOI] [PubMed] [Google Scholar]
  42. Perryman L. E., McGuire T. C., Banks K. L., Henson J. B. Decreased C3 levels in a chronic virus infection: equine infectious anemia. J Immunol. 1971 Apr;106(4):1074–1078. [PubMed] [Google Scholar]
  43. Rager-Zisman B., Allison A. C. The role of antibody and host cells in the resistance of mice against infection by coxsackie B-3 virus. J Gen Virol. 1973 Jun;19(3):329–338. doi: 10.1099/0022-1317-19-3-329. [DOI] [PubMed] [Google Scholar]
  44. Rittenberg M. B., Pratt K. L. Antitrinitrophenyl (TNP) plaque assay. Primary response of Balb/c mice to soluble and particulate immunogen. Proc Soc Exp Biol Med. 1969 Nov;132(2):575–581. doi: 10.3181/00379727-132-34264. [DOI] [PubMed] [Google Scholar]
  45. Rola-Pleszczynski M., Hurtado R. C., Woody J. N., Sell K. W., Vincent M. M., Hensen S. A., Bellanti J. A. Identification of the cell population involved in viral-specific cell-mediated cytotoxicity in man: evidence for T cell specificity. J Immunol. 1975 Jul;115(1):239–242. [PubMed] [Google Scholar]
  46. Rouse B. T., Babiuk L. A. Host responses to infectious bovine rhinotracheitis virus. III. Isolation and immunologic activities of bovine T lymphocytes. J Immunol. 1974 Nov;113(5):1391–1398. [PubMed] [Google Scholar]
  47. Rouse B. T., Babiuk L. A. The direct antiviral cytotoxicity by bovine lymphocytes is not restricted by genetic incompatibility of lymphocytes and target cells. J Immunol. 1977 Feb;118(2):618–624. [PubMed] [Google Scholar]
  48. Rouse B. T., Wardley R. C., Babiuk L. A. Antibody-dependent cell-mediated cytotoxicity in cows: comparison of effector cell activity against heterologous erthrocyte and herpesvirus-infected bovine target cells. Infect Immun. 1976 May;13(5):1433–1441. doi: 10.1128/iai.13.5.1433-1441.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Rouse B. T., Wardley R. C., Babiuk L. A. The role of antibody dependent cytotoxicity in recovery from herpesvirus infections. Cell Immunol. 1976 Mar 1;22(1):182–186. doi: 10.1016/0008-8749(76)90019-8. [DOI] [PubMed] [Google Scholar]
  50. Russell A. S., Percy J. S., Kovithavongs T. Cell-mediated immunity to Herpes simplex in humans: lymphocyte cytotoxicity measured by 51-Cr release from infected cells. Infect Immun. 1975 Feb;11(2):355–359. doi: 10.1128/iai.11.2.355-359.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Santoli D., Trinchieri G., Koprowski H. Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells. J Immunol. 1978 Aug;121(2):532–538. [PubMed] [Google Scholar]
  52. Santoli D., Trinchieri G., Lief F. S. Cell-mediated cytotoxicity against virus-infected target cells in humans. I. Characterization of the effector lymphocyte. J Immunol. 1978 Aug;121(2):526–531. [PubMed] [Google Scholar]
  53. Shore S. L., Black C. M., Melewicz F. M., Wood P. A., Nahmias A. J. Antibody-dependent cell-mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus. J Immunol. 1976 Jan;116(1):194–201. [PubMed] [Google Scholar]
  54. Sugamura K., Smith J. B. Reversible blocking of antibody-dependent cell-mediated cytotoxicity. Cell Immunol. 1977 May;30(2):353–357. doi: 10.1016/0008-8749(77)90078-8. [DOI] [PubMed] [Google Scholar]
  55. Tajima M., Nakajima H., Ito Y. Electron microscopy of equine infectious anemia virus. J Virol. 1969 Oct;4(4):521–527. doi: 10.1128/jvi.4.4.521-527.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Welsh R. M., Jr Mouse natural killer cells: induction specificity, and function. J Immunol. 1978 Nov;121(5):1631–1635. [PubMed] [Google Scholar]
  57. Wisloff F., Michaelsen T. E., Froland S. S. Inhibition of antibody-dependent human lymphocyte-mediated cytotoxicity by immunoglobulin classes, IgG subclasses, and IgG fragments. Scand J Immunol. 1974;3(1):29–38. doi: 10.1111/j.1365-3083.1974.tb01230.x. [DOI] [PubMed] [Google Scholar]
  58. Woan M. C., Yip D. M., Tompkins W. A. Autochthonous, allogeneic, and exenogeneic cells as targets for vaccinia immune lymphocyte cytotoxicity. J Immunol. 1978 Jan;120(1):312–316. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES